Boothbay Fund Management’s Universal Display OLED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Sell
4,135
-1,897
-31% -$175K ﹤0.01% 1672
2026
Q1
$553K Buy
+6,032
New +$667K 0.01% 1289
2025
Q2
Sell
-4,630
Closed -$646K 1692
2025
Q1
$646K Buy
4,630
+1,279
+38% +$191K 0.02% 774
2024
Q4
$490K Sell
3,351
-4,992
-60% -$889K 0.01% 874
2024
Q3
$1.75M Sell
8,343
-10,869
-57% -$2.2M 0.04% 563
2024
Q2
$4.04M Buy
+19,212
New +$3.38M 0.1% 285
2022
Q3
Sell
-2,777
Closed -$281K 2499
2022
Q2
$281K Buy
+2,777
New +$357K 0.01% 1503
2021
Q4
Sell
-1,695
Closed -$290K 2122
2021
Q3
$290K Buy
+1,695
New +$351K 0.01% 1355
2017
Q4
Sell
-6,781
Closed -$874K 788
2017
Q3
$874K Sell
6,781
-1,153
-15% -$139K 0.15% 164
2017
Q2
$867K Sell
7,934
-66
-0.8% -$6.95K 0.18% 121
2017
Q1
$689K Buy
+8,000
New +$576K 0.13% 194

Other funds holding OLED

Boothbay Fund Management's OLED Position: Q2 2026 in Review

Boothbay Fund Management reduced its Universal Display (OLED) stake by 31% in Q2 2026, selling an estimated $175K and leaving 4,135 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Boothbay Fund Management first reported a position in OLED in Q1 2017 and has held it in 11 quarters since. The position peaked at $4.04M in Q2 2024. 443 funds tracked by Wall St. Rank hold OLED as of Q2 2026.

  • Boothbay Fund Management held 4,135 shares of Universal Display worth $358K as of Q2 2026.
  • Boothbay Fund Management sold 1,897 Universal Display shares in Q2 2026, an estimated $175K.
  • Universal Display made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1672 holding.
  • Boothbay Fund Management first reported a position in Universal Display in Q1 2017 and has held it in 11 quarters since.
  • Boothbay Fund Management's Universal Display position peaked at $4.04M in Q2 2024.
  • 443 funds tracked by Wall St. Rank held Universal Display as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.